Pomalidomide-C2-NH2 (hydrochloride) is a functionalized analog of pomalidomide widely utilized in PROTAC drug development as an E3 ligase ligand. This compound incorporates an aminoalkyl linker (C2-NH2) at the relevant site on the pomalidomide scaffold, enabling effective conjugation to target-binding domains for the creation of cereblon (CRBN)-based PROTACs and molecular glues. By hijacking the ubiquitin-proteasome system, PROTACs designed with Pomalidomide-C2-NH2 (hydrochloride) can induce selective degradation of disease-related proteins. This product is ideal for researchers developing next-generation targeted protein degradation tools in oncology, neurodegeneration, and other therapeutic areas.
Structure of 2305369-00-8
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
Pomalidomide is a next-generation immunomodulatory imide drug (IMiD) structurally related to thalidomide and lenalidomide, renowned for its improved potency and reduced off-target effects. As a high-affinity ligand for Cereblon (CRBN), an E3 ubiquitin ligase, pomalidomide is a popular choice in targeted protein degradation research. Pomalidomide-C2-NH2 (hydrochloride) is a pomalidomide derivative featuring a two-carbon (C2) amino linker, which offers enhanced versatility for conjugation and synthetic construction of PROTAC (Proteolysis Targeting Chimera) molecules.
Mechanism
Pomalidomide-C2-NH2 (hydrochloride) selectively binds to the CRBN substrate adaptor of the CUL4-CRBN E3 ubiquitin ligase complex. By linking this ligand to a molecule that binds a protein of interest, it acts as a PROTAC E3 ligase recruiter, facilitating the proximity-induced ubiquitination and subsequent proteasomal degradation of the target protein. The C2-amino linker provides a chemically accessible site for further modification, allowing seamless incorporation into larger bifunctional PROTACs with optimized pharmacokinetics and cellular activity.
Applications
Pomalidomide-C2-NH2 (hydrochloride) is widely employed in the design and synthesis of CRBN-based PROTACs and molecular glues for targeted protein degradation. The compound's C2-amino linker supports strategic conjugation with various ligands, enabling rapid exploration of structure-activity relationships (SAR) and fine-tuning of degrader properties. Researchers utilize this E3 ligase ligand for:
• Assembly of customized CRBN-targeting PROTAC libraries
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.